Author Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103⁺ dendritic cell differentiation

Affiliations

• ¹ Center for Brain Disorders Research, Capital Medical University, Beijing, 100069, China.
• ² Beijing Institute for Brain Disorders, Beijing, 100069, China.
• ³ Department of Pediatrics-Research, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
• ⁴ Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
• ⁵ Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
• ⁶ Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
• ⁷ Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
• ⁸ Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. [email protected].
• ⁹ Department of Pediatrics-Research, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. [email protected].